Neoadjuvant Treatment For Locally Advanced Thymic Cancer

NCT06019468 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Thymic Carcinoma

Interventions

OTHER: Envolizumab combined with radiotherapy

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China